[1]王玉廷,阳文琳.公立医院DRG临床路径管控方案探索及效果评价[J].卫生经济研究,2024,41(07):71-75.
 WANG Yuting,YANG Wenlin.Exploration and Effect Evaluation of DRG-based Clinical Pathway Control Program in Public Hospitals[J].Journal Press of Health Economics Research,2024,41(07):71-75.
点击复制

公立医院DRG临床路径管控方案探索及效果评价
分享到:

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年07期
页码:
71-75
栏目:
改革探索
出版日期:
2024-07-03

文章信息/Info

Title:
Exploration and Effect Evaluation of DRG-based Clinical Pathway Control Program in Public Hospitals
作者:
王玉廷1阳文琳1
1. 重庆医科大学附属第二医院,重庆400010
Author(s):
WANG Yuting YANG Wenlin
The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
关键词:
疾病诊断相关分组临床路径效果评价
Keywords:
Diagnosis Related Groups clinical pathway effect evaluation
分类号:
F840.684
文献标志码:
A
摘要:
目的:探索基于DRG的临床路径管理方案,评价其实施效果。方法:选取重庆市医保局本土化DRG分组后的数据进行分析,采用Wilcoxon秩和检验对比评估临床路径效果。结果:实行基于DRG的临床路径管控后,不同分组的患者住院费用有效降低,且差异具有统计学意义;DRG组层面,相比非路径组,RE13、RW19、CB19等路径组住院费用均降低且具有统计学意义;同一DRG组的检查费、药品费、耗材费、治疗费及其他费用均有效降低,且差异均有统计学意义。结论:基于DRG的临床路径管理可以通过有效降低具体病种费用,最终达到控制医疗支出、节约医保基金的目的。
Abstract:
Objective To explore the DRG-based clinical path control program, and to evaluate its implementation effect. Methods The data after the localized DRG grouping of Chongqing Municipal Healthcare Security Administration were selected for analysis, and the Wilcoxon rank sum test was used to compare and evaluate the effect of clinical pathways. Results After the implementation of DRG-based clinical pathway control, the hospitalization costs of patients in different subgroups were effectively reduced, and the differences were statistically significant. At the level of DRG groups, compared with non-pathway groups, the hospitalization costs of pathway groups such as RE13, RW19, and CB19 were reduced, and the differences were statistically significant. The costs of examination, medicine, consumables, treatment, and other costs in the same DRG group were effectively reduced, and the differences were statistically significant. Conclusion DRG-based clinical pathway management can effectively reduce the costs of specific diseases, and ultimately achieve the purpose of controlling medical expenditures and saving health insurance funds.

参考文献/References:

[1] 于婷,严波.DRG付费方式下公立医院结余分析与运营策略研究[J].中国医院,2022,26(10):64-66.
[2] 王玉廷,周小兰,阳文琳.基于细化疾病诊断相关分组病种临床路径管理方案的制订及实施效果分析[J].检验医学与临床,2023,20(08):1068-1071.
[3] 曹坤,蔡双宁,陈维敏.基于BP人工神经网络模型实现DRG与临床路径管理融合与优化[J].医院管理论坛,2022,39(04):15-17,14.
[4] 王玉廷,周小兰,沈毅,等.DRG支付下医院住院医疗成本管理及控制[J].卫生经济研究,2021,38(09):58-61.
[5] 李梦滢,孙志成,唐尧,等.基于DRG的公立医院临床路径管理体系建设[J].卫生经济研究,2022,39(02):67-69,74.
[6] 邵晓军,马洪兰,蒋伊石.DRG和卫生经济学评价共筑临床路径新模式[J].中国医院院长,2023,19(19):75-77.
[7] 张宏亮,章忠明,陈凤磊,等.DRG背景下基于循证药学制订药物治疗临床路径实践探索[J].中国医院,2022,26(02):16-18.
[8] 吴龙昌,温玲珠.关节镜下胫骨平台骨折手术治疗中临床路径的实施及效果评价[J].临床医学研究与实践,2018,3(01):46-48.
[9] 谷成胜,石平,何明方,等. DRG支付制度下的临床路径实施效果评价研究——基于间断时间序列模型[J].中国医疗保险,2022(05):11-16.
[10] 郑丽敏,陈新平,林镇江.以医疗质量为基础的DRG核心要素调整机制研究[J].卫生经济研究,2023,40(08):33-36.
[11] 雷志勤,史晓川,雷亚明.基于精准化的大型公立医院成本管控实践研究[J].中国医院管理,2021,41(06):46-48.

相似文献/References:

[1]薛林南,张 晶,刘 珊,等.医院入组病例未按DRGs结算原因分析[J].卫生经济研究,2016,(05):28.
[2]裴 敬,周晓容,李家伟,等.新农合单病种支付方式改革现状与对策研究[J].卫生经济研究,2017,(01):32.
[3]肖云芳,何 宇,杨小丽.医养结合发展热潮的冷思考[J].卫生经济研究,2017,(08):22.
[4]易颜新,陆稼天,黄莉媛,等.基于ABC-DRGs的公立医院病种成本研究[J].卫生经济研究,2018,(03):44.
[5]徐小平,于千惠,邓东宁,等.DRGs在医院管理中应用的研究现状[J].卫生经济研究,2018,(05):66.
[6]于保荣.按病例支付及医疗服务支付方式改革的实现条件——从DRGs、按病种付费、点数法付费及临床路径谈起[J].卫生经济研究,2018,(09):16.
 YU Bao-rong.Conditions for the Implementation of Reforms by Case Payment and Payment for Medical Services ——From DRGs,Case-based payments,Point payments,and Clinical pathways[J].Journal Press of Health Economics Research,2018,(07):16.
[7]胡安霞,王嘉祁,肖 健,等.基于DRGs的三甲综合医院住院服务绩效评价研究[J].卫生经济研究,2018,(12):55.
 HU An-xia,WANG Jia-qi,XIAO Jian,et al.Research on Performance Evaluation of Inpatient Service in Grade IIIA General Hospital Based on DRGs[J].Journal Press of Health Economics Research,2018,(07):55.
[8]张文娟,宋厚斌,王新虹,等.基于临床路径的按病种付费分段控制标准化构建[J].卫生经济研究,2019,(07):36.
 ZHANG Wen-juan,SONG Hou-bin,WANG Xin-hong,et al.Standardized Construction of Disease-based Segmentation Control Based on Clinical Path[J].Journal Press of Health Economics Research,2019,(07):36.
[9]郑 晨.运用DRG进行医院精准控费的实践探索[J].卫生经济研究,2019,(09):54.
 ZHENG Chen.Practical Exploration of Using DRG to Carry out Accurate Fees Control in Hospitals[J].Journal Press of Health Economics Research,2019,(07):54.
[10]王国强,张会会,焦婷婷,等.DRG在医院心血管内科专业绩效管理中的应用[J].卫生经济研究,2019,(09):57.
 WANG Guo-qiang,ZHANG Hui-hui,JIAO Ting-ting,et al.Application of DRGS in the Performance Management of Cardiovascular Internal Medicine in Hospital[J].Journal Press of Health Economics Research,2019,(07):57.
[11]王国林.DRG支付下歧义病例的成因及对策研究[J].卫生经济研究,2024,41(12):21.
 WANG Guolin.Study on the Causes Countermeasure of QY Cases under DRG Payment System[J].Journal Press of Health Economics Research,2024,41(07):21.

更新日期/Last Update: 2024-07-03